NCT01280344

Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function

Phase II Double-Blind Placebo-Controlled Dose Finding Study to Evaluate Safety/Efficacy of Ipamorelin Compared to Placebo for Recovery of Gastrointestinal Function in Patients Following Small or Large Bowel Resection w/Primary Anastomosis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 320 (actual)
• Sponsor: Helsinn Therapeutics (U.S.), Inc · Industry
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

Post-operative administration of ipamorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial small and/or large bowel resection.

Conditions

• Gastrointestinal Dysmotility

Interventions

Type	Name	Description
DRUG	Saline Solution for Injection	Intravenous (IV)
DRUG	Ipamorelin	Intravenous (IV)

Timeline

• Start date: 2011-04-01
• Primary completion: 2013-06-01
• Completion: 2014-05-01
• First posted: 2011-01-20
• Last updated: 2017-04-13

Locations

45 sites across 1 country: United States